InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by GRAHAM PETER J, Directeur Juridique. Director active across 1 companies, notably Antares Pharma, INC.. Cumulatively, 8 reports have been logged. The latest transaction was disclosed on 24 May 2022 — Disposition. Regulator: SEC (Form 4). The full history is free.
Declarations8 total
€2m414,470 shares@ €5.215874.5% of flow
Common Stock
SEC:0000899243-22-019789:0·
026,044 shares0
Common Stock
SEC:0001016169-22-000031:0·
023,068 shares0
Common Stock
SEC:0001016169-22-000016·
023,068 shares0
Common Stock
SEC:0001016169-22-000016:0·
€312,17885,973 shares@ €3.631184.4% of flow
Common Stock
SEC:0001209191-21-040328·
€312,17885,973 shares@ €3.631110.8% of flow
Common Stock
SEC:0001209191-21-040328:0·
€57,68815,996 shares@ €3.606415.6% of flow
Common Stock
SEC:0001209191-21-039591·
€57,68815,996 shares@ €3.60642.0% of flow
Common Stock
SEC:0001209191-21-039591:0·
8 of 8 declarations
About GRAHAM PETER J
Peter J. Graham is Executive Vice President, General Counsel, and Secretary at Antares Pharma, Inc. He is responsible for the company's legal affairs and ensures regulatory compliance. His expertise is crucial for protecting the organization's interests.
